Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Efficacy and Safety of Tazbentetol in ALS Participants

Study ID: NCT07325591
Start Date: 2026-03-01
End Date: 2028-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

336

Intervention / Treatment

Tazbentetol 300 mg once daily

placebo

Tazbentetol 300 mg twice daily

Sponsor

Spinogenix

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Study ID: NCT06801223
Start Date: 2026-02-28
End Date: 2028-05-20
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours)

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours)

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)

Sponsor

Innoviva Specialty Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Harmonized Healing: Personalized Music Interventions to Address Chronic Pain in People Living With HIV

Study ID: NCT07214077
Start Date: 2026-06
End Date: 2028-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Harmonized Healing App

Psychoeducation

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

Study ID: NCT07218575
Start Date: 2026-04
End Date: 2030-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

60

Intervention / Treatment

Everolimus blinded oral capsules

Placebo

Sponsor

Boston Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Whole-Body Electrostimulation for Functional Recovery in Post-COVID Syndrome

Study ID: NCT07312357
Start Date: 2026-03
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Whole-Body Electromyostimulation Suit

Sponsor

King Juan Carlos University

Source: clinicaltrials.gov

Share:
Add to list

Mindfulness Training During Accelerated iTBS for Depression (MB-TBS)

Study ID: NCT07369557
Start Date: 2026-02-20
End Date: 2026-08-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Guided Mindfulness Practice (Healthy Minds app)

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury

Study ID: NCT05217498
Start Date: 2027-09-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Istradefylline

low oxygen therapy

Sponsor

Randy Trumbower, PT, PhD

Source: clinicaltrials.gov

Share:
Add to list

ArcFlex Sheath in TAVR Trial

Study ID: NCT07320274
Start Date: 2026-03-01
End Date: 2030-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

ArcFlex Sheath

ordinary sheath

Sponsor

Sun Yat-sen University

Source: clinicaltrials.gov

Share:
Add to list

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

Study ID: NCT07128680
Start Date: 2026-04-01
End Date: 2027-06-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

33

Intervention / Treatment

Biospecimen Collection

Bone Scan

Computed Tomography

Faecalibacterium prausnitzii-containing Bacterial Strain Formulation EXL01

Ipilimumab

Magnetic Resonance Imaging

Nivolumab

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy

Study ID: NCT05646524
Start Date: 2026-04
End Date: 2028-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

NM8074

Sponsor

NovelMed Therapeutics

Source: clinicaltrials.gov

Share:
Add to list